Maynooth University researchers found one Melanotan sample held just 40% of the stated peptide, and all four products had an undisclosed bulking agent.
Recap by typeshit. Full story at RTE.ie.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Weight loss and diabetes drugs bring in more than 60% of Lilly's revenue, and Forbes looks at where the CEO is putting billions next.
Reported effects of the gray-market triple agonist range from gut problems to burning skin, panic attacks and depression.
Loading…